Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
IRWD
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -32.5%
IRWD
Ironwood Pharmaceuticals, Inc. - Class A
☁️ News word cloud
Top words across the last 50 articles for this ticker.
ironwood
nasdaq
trading
last
stocks
price
rating
pharmaceuticals
compared
high
period
after
nyse
estimates
linzess
rose
gained
therapeutics
closed
expected
StonvexStonvexStonvexStonvex